Announcements Trials
Browse Landscape

Status

Completed 10Unknown 6Recruiting 4Active not recruiting 4Withdrawn 1

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 33Observational 6

Sponsor

Cancer Type

Thoracic 4Dermatologic 4Genitourinary 1CNS 1

Conditions

Melanoma 4Neoplasms 3Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Kidney Neoplasms 1Brain Neoplasms 1

Interventions

Blood Specimen Collection 85Surveys and Questionnaires 83Surgical Procedures, Operative 44Drug Therapy 32Radiotherapy 27Biopsy 26Amplified Fragment Length Polymorphism Analysis 24Neoadjuvant Therapy 23Immunohistochemistry 22Gene Expression Profiling 21Bevacizumab 19Data Collection 18Immunotherapy 17Ultrasonography 16Positron Emission Tomography Computed Tomography 16Magnetic Resonance Spectroscopy 16Liquid Biopsy 16pembrolizumab 15Nivolumab 15Watchful Waiting 14Radiosurgery 14Observation 14Microarray Analysis 14Magnetic Resonance Imaging 14Interviews as Topic 14Immune Checkpoint Inhibitors 13Colonoscopy 13Capecitabine 13Polymerase Chain Reaction 12Paclitaxel 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × Observational × Ipilimumab × Clear all
NCT03458455 2023-11-01

TREATMENT

Oslo University Hospital

Unknown
200 enrolled
CNS

Brain Neoplasms

NCT04107168 2023-02-16

Microbiome Immunotherapy Toxicity and Response Evaluation

Cambridge University Hospitals NHS Foundation Trust

Unknown
1,800 enrolled
DermatologicGenitourinaryThoracic

Kidney Neoplasms, Lung Neoplasms, Melanoma

NCT04860076 2021-04-26

Open-label, Uncontrolled, Non-Interventional, Retrospective Study to Evaluate Molecular Determinants of Outcome to the Immune Checkpoint Inhibitors (Anti-PD-1/Anti-PD-L1 Monoclonal Antibodies) Treatment for Solid Tumors

Asylia Diagnostics BV

Unknown
400 enrolled
DermatologicThoracic

Lung Neoplasms, Melanoma

NCT04136470 2020-08-10

BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

Ardigen

Unknown
130 enrolled
DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms

NCT04145232 2020-08-10

AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.

Ardigen

Unknown
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT04169867 2019-11-20

Polish Microbiome Map

Ardigen

Unknown
1,160 enrolled
Dermatologic

Melanoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡